not tagged
pds biotech
['pivotal', '$pdsb']
$pdsb correction: cpi refractory- orr is 63% at asco 2022 vs 47% asco 2021 remember high dose m9241 matters not low lose because high dose m9241 used for asco nci 2021 trial data high dose m9241 will be part of pivotal ph3 trial. 
USC Alumni, Full Time Investor. My tweets are just my own opinions and not a recommendation. Please do your own due diligence.